MAR 22, 2018 07:00 AM PDT

Emerging Diagnostic Strategies to Support C. difficile Infection Control

SPONSORED BY: Roche Diagnostics
C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Epidemiologist, North Shore University Health System, Clinical Professor, Pritzker School of Medicine, University of Chicago
      My practice and research interests have included the study of infections in the extremities of diabetic patients; investigations of antimicrobial agents in models that simulate closed space, neutropenic infections; the epidemiology of nosocomial pathogens (particularly MRSA, enterococci, MDR Gram negative bacteria, and Clostridium difficile); the development and evaluation of molecular diagnostic testing; measuring activity of new antimicrobial compounds against bacteria and fungi; and the study of the molecular mechanisms for the resistance of staphylococci to antibiotics, and pneumococci to the new fluoroquinolone antimicrobial agents. Our current research activities focus on using molecular testing methods to enhance infection control activities; understanding the regulation of antimicrobial agent resistance in staphylococci and Enterobacteriaceae; designing novel strategies for treatment of infections due to resistant bacteria; testing innovations to reduce catheter-related blood stream and urinary tract infections; and developing new diagnostic tests for rapidly detecting antibiotic resistant bacterial pathogens.


    DATE: March 22, 2018
    TIME: 07:00am PDT, 10:00am EDT

    Clostridium difficile (C. diff) is a highly problematic healthcare-associated infection that is easily spread and often results in poor outcomes and high costs. Furthermore, the epidemiology of C. diff is changing, with increases in both incidence and severity in recent years. According to CDC, C. diff caused nearly half a million infections in the United States in 2011, and 29,000 deaths within 30 days of the initial diagnosis.1

     To manage this challenging infection, a multi-faceted approach involving contact precautions, environmental cleaning, rapid diagnostics, and related strategies is required. This webinar will provide an overview of the issues surrounding C. diff and highlight novel strategies employed by the microbiology lab to support accurate diagnosis and prevention.

    1Centers for Disease Control and Prevention. “Clostridium difficile infection.” Available at:  (accessed January 31, 2018).

    Learning Objectives:

    • Describe the impact of C. diff from a clinical and cost perspective
    • Understand the epidemiology of C. diff
    • Demonstrate the role of the microbiology lab in diagnosis and prevention

    Show Resources
    Loading Comments...